Literature DB >> 29111500

The moral hazard effects of consumer responses to targeted cost-sharing.

Christopher M Whaley1, Chaoran Guo2, Timothy T Brown3.   

Abstract

This paper examines the effects of the reference pricing program implemented by the California Public Employees Retirement System (CalPERS) in 2012. The program uses targeted cost-sharing to incentivize patient price shopping. We find that the program leads to a 10.3% increase in the use of low-price providers and reduces the average cost per procedure by 12.5%. We further estimate that the program reduces medical spending by $218.8 per procedure, which we estimate is approximately 53.7% of the excessive spending that is due to patient choice of higher price providers caused by insurance coverage, at the expense of a $94.3 (or 12.5%) reduction in consumer surplus. The cost savings from the reference pricing program is about two to three times as large as the reduction from implementing a high-deductible health plan, while the accompanying consumer surplus reduction is much smaller under reference pricing.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Insurance benefit design; Moral hazard; Reference pricing

Mesh:

Year:  2017        PMID: 29111500      PMCID: PMC5821148          DOI: 10.1016/j.jhealeco.2017.09.012

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  18 in total

1.  A new estimate of the welfare loss of excess health insurance.

Authors:  R Feldman; B Dowd
Journal:  Am Econ Rev       Date:  1991-03

2.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

3.  Consumer Choice Between Hospital-Based and Freestanding Facilities for Arthroscopy: Impact on Prices, Spending, and Surgical Complications.

Authors:  James C Robinson; Timothy T Brown; Christopher Whaley; Kevin J Bozic
Journal:  J Bone Joint Surg Am       Date:  2015-09-16       Impact factor: 5.284

4.  Reference-based benefit design changes consumers' choices and employers' payments for ambulatory surgery.

Authors:  James C Robinson; Timothy Brown; Christopher Whaley
Journal:  Health Aff (Millwood)       Date:  2015-03       Impact factor: 6.301

5.  The Impact of a Tiered Network on Hospital Choice.

Authors:  Matthew B Frank; John Hsu; Mary Beth Landrum; Michael E Chernew
Journal:  Health Serv Res       Date:  2015-03-09       Impact factor: 3.402

6.  Selection on Moral Hazard in Health Insurance.

Authors:  Liran Einav; Amy Finkelstein; Stephen Ryan; Paul Schrimpf; Mark R Cullen
Journal:  Am Econ Rev       Date:  2013-02

7.  THE RESPONSE OF DRUG EXPENDITURE TO NON-LINEAR CONTRACT DESIGN: EVIDENCE FROM MEDICARE PART D.

Authors:  Liran Einav; Amy Finkelstein; Paul Schrimpf
Journal:  Q J Econ       Date:  2015-02-08

8.  Estimating the Tradeoff Between Risk Protection and Moral Hazard with a Nonlinear Budget Set Model of Health Insurance.

Authors:  Amanda E Kowalski
Journal:  Int J Ind Organ       Date:  2015-11-01

9.  Digesting the doughnut hole.

Authors:  Geoffrey F Joyce; Julie Zissimopoulos; Dana P Goldman
Journal:  J Health Econ       Date:  2013-05-06       Impact factor: 3.883

10.  Association of Reference Payment for Colonoscopy With Consumer Choices, Insurer Spending, and Procedural Complications.

Authors:  James C Robinson; Timothy T Brown; Christopher Whaley; Emily Finlayson
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

View more
  2 in total

Review 1.  Demand-side Interventions to Control Moral Hazard in Health Systems, Beneficial or Detrimental: A Systematic Review Study.

Authors:  Zohreh Koohi Rostamkalaee; Mehdi Jafari; Hasan Abolghasem Gorji
Journal:  Med J Islam Repub Iran       Date:  2022-06-27

2.  Paying patients to use lower-priced providers.

Authors:  Christopher Whaley; Neeraj Sood; Michael Chernew; Leanne Metcalfe; Ateev Mehrotra
Journal:  Health Serv Res       Date:  2021-08-09       Impact factor: 3.734

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.